# BioNexus Gene Lab Corp: Form 8-K, filed Dec 30, 2025

- Company: [BioNexus Gene Lab Corp](/companies/bglc.md) (CIK 1737523)
- Form: 8-K
- Filed: 2025-12-30
- Accepted by EDGAR: Dec 30, 2025, 18:30 ET
- Period: 2025-12-24
- Accession: 0001477932-25-009240
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1737523/000147793225009240/bglc_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1737523/000147793225009240/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1737523/000147793225009240/bglc_8k.htm

Filed Dec 30, 2025.
Source: SEC EDGAR, the filing index for accession 0001477932-25-009240. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.